Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$76,288,029
-$66,414,269 QoQ
Shares Held
8,098,517
-2.1% QoQ
Ownership
8.56%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 99.96808057573998.ToString("F0")%
Shared 0.ToString("F0")%
None 0.03191942426002193.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Dec 31, 2024CallValue
$5,595,000
CallShares
300,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,293,152,367 across 364 Biotechnology names. FTRE ranks #34 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in FTRE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,288,029 | 8,098,517 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $142,702,298 | 8,272,597 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $67,179,853 | 7,978,605 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $39,023,529 | 7,899,500 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,637,219 | 481,751 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $6,994,234 | 375,026 | Shares | Defined | 2025-02-11 | |
| 2024-12-31 | $5,595,000 | 300,000 | Call | Defined | 2025-02-11 | |
| 2024-09-30 | $9,862,880 | 493,144 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,853,824 | 507,876 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $21,186,893 | 527,825 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,758,479 | 222,306 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,330,534 | 116,493 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||